Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmic Business News
PBMs vs. patients: The hidden battle for affordable biosimilars
Biosimilar medications — drugs developed to be very similar, but not identical, to an FDA-approved biologic — were intended to play a vital role in increasing affordable options for patients struggling with a range of chronic conditions.
Innovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)
In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care.
Log in or Sign up for Free to view tailored content for your specialty!
FDA clears investigational new drug application for photoreceptor disease therapy
The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.
Qualified retirement plans offer pros and cons for practice owners and employees
Retirement planning for physicians is a critical aspect of financial management, given the unique challenges and opportunities they face.
VIDEO: Elios Vision to launch excimer laser for glaucoma in 2025
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cari Stone of Elios Vision previews the company’s excimer laser for the treatment of glaucoma.
VIDEO: Save early, understand retirement account taxes when building wealth
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Carole C. Foos, CPA, of OJM Group discusses saving and investing pearls for ophthalmologists.
European Commission grants marketing authorization to Akantior for Acanthamoeba keratitis
The European Commission granted marketing authorization to Akantior for the treatment of Acanthamoeba keratitis, according to a press release from Avanzanite Bioscience.
Dollar cost averaging and lump sum investing: Time in the market is key
Most physicians receive a regular paycheck, and sometimes receive a lump sum such as a bonus. A proportion of both should be invested. How should one invest a portion of their regular paycheck?
Icare Finland Oy acquires Thirona Retina
Icare Finland Oy, a subsidiary of Revenio Group, has signed an agreement to acquire the AI software company Thirona Retina, according to a press release.
FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy
Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read